Clinical Trials in Nashville

Showing 1921-1940 of 9,711 trials

Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

NCT02785848

The investigators will explore barriers to improving self-efficacy, or the ability to feel in control of their disease, and medication adherence with text messaging through surveys and interviews with adolescents and adults with SCD cared for at the Vanderbilt Meharry Center of Excellence (VMCE) in Sickle Cell Disease (SCD). The investigators will identify preferences to improve and sustain adherence to daily medication through selection of investigator-proposed or patient-generated text messaging strategies. Finally, the investigators will fill in the literature gaps by describing barriers to self-efficacy and medication adherence among adults with SCD as well as adolescents with SCD who are transitioning to adult care.

Sickle Cell Disease

Vanderbilt University70 participantsStarted May 2016

Nashville, Tennessee, United States

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

NCT05107128

The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance and functioning in participants with HD.

Huntington's Disease

Supernus Pharmaceuticals, Inc.189 participantsStarted Jan 2022

Little Rock, Arkansas, United States • La Jolla, California, United States • Los Angeles, California, United States +46 more locations

Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

Find Trials by Condition in Nashville

Co-Use of Opioid Medications and Alcohol Prevention Study

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

Assessing the Time Demands of Cancer

Omnipod 5 System Compared to Pump Therapy

The Use of Mentoring to Promote Well-being for Female SMART Members

Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children

PRO 140 in Treatment-Experienced HIV-1 Subjects

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

BlueWind RENOVA iStim™ System for the Treatment of OAB

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

Locking Plates for Distal Femur Fractures - a Multicenter Case Review